Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Blood|August 31, 2012
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cellsMarta Coscia, Candida Vitale, Silvia Peola, et al.
Blood|February 28, 2004
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disordersMarco Ladetto, Mara Compagno, Irene Ricca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapyMarco Ladetto, Daniela Drandi, Mara Compagno, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myelomaMarco Ladetto, Gloria Pagliano, Simone Ferrero, et al.
Blood|September 13, 2007
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesisSimona Colla, Sara Tagliaferri, Francesca Morandi, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCRDaniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Haematologica|July 2, 2013
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana LinfomiAnnalisa Chiappella, Alessandra Tucci, Alessia Castellino, et al.
American Journal of Hematology|December 16, 2014
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphomaLuca Arcaini, Lucia Morello, Alessandra Tucci, et al.
JCO Clinical Cancer Informatics|October 22, 2019
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical OutcomesGian Maria Zaccaria, Simone Ferrero, Samanta Rosati, et al.
Pageof 14